Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients
BACKGROUND: The immune pathogenesis underlying the diverse clinical course of COVID-19 is poorly understood. Currently, there is an unmet need in daily clinical practice for early biomarkers and improved risk stratification tools to help identify and monitor COVID-19 patients at risk of severe disease.METHODS: We performed longitudinal assessment of stimulated immune responses in 30 patients hospi
